WATCH: The challenges of returning to sport

Insights from the study of protein alpha-synuclein could lead to earlier detection of the neurogenerative disease.

Manikomycin, which blocks the exit site of the protein-producing machinery in bacteria, is the fourth major discovery from antimicrobial resistance expert Gerry Wright’s research team in recent months.

The study finds only moderate consistency in the results of standardized diagnostic interviews for adult mental and substance use disorders.